For research use only
| Cat No. | ABC-TC3171 |
| Product Type | Mouse Primary Cells |
| Cell Type | Macrophage |
| Species | C57BL/6 Mouse |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bone Marrow |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Mouse Bone Marrow Macrophages are derived from the tibias and femurs of pathogen-free laboratory adult mice.
C57BL/6 Mouse Bone Marrow Macrophages are primary cells isolated from the tibias and femurs of pathogen-free laboratory mice and serve as an ideal model for studying hematopoietic regulation in C57BL/6 mice. Following primary culture, these cells are cryopreserved. These specialized macrophages play a dual role in maintaining the hematopoietic niche through supportive signaling and secretion of key regulatory factors (CXCL12, SCF, IL-6), while also orchestrating bone remodeling via osteoclast regulation. Their dysfunction is linked to myelodysplastic syndromes, osteoporosis, and chemotherapy-induced bone marrow suppression. C57BL/6 Mouse Bone Marrow Macrophages are characterized using antibodies against CD11b and F4/80. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | C57BL/6 Mouse Bone Marrow Macrophages, C57BL/6 BMM, B6 BM Macrophages, C57BL6 BM-Macs |
| Species | C57BL/6 Mouse |
| Cat.No | ABC-TC3171 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Macrophage |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bone Marrow |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Mouse Primary Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
C57BL/6 Mouse Bone Marrow Macrophages serve as a powerful in vitro model to study hematopoietic niche dysfunction in disease conditions such as chemotherapy-induced bone marrow suppression. For example, by analyzing their regulatory pathways in CXCL12/SCF secretion and VCAM-1-mediated HSC anchoring, this approach provides insights into the physiological maintenance of hematopoiesis and pathological bone marrow failure mechanisms, facilitating the development of targeted niche-repair therapies.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).